Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Respiratory paralysis
ADR ID BADD_A03815
ADR Hierarchy
17      Nervous system disorders
17.01      Movement disorders (incl parkinsonism)
17.01.04      Paralysis and paresis (excl cranial nerve)
17.01.04.010      Respiratory paralysis
22      Respiratory, thoracic and mediastinal disorders
22.02      Respiratory disorders NEC
22.02.06      Respiratory failures (excl neonatal)
22.02.06.003      Respiratory paralysis
Description Complete or severe weakness of the muscles of respiration. This condition may be associated with MOTOR NEURON DISEASES; PERIPHERAL NERVE DISEASES; NEUROMUSCULAR JUNCTION DISEASES; SPINAL CORD DISEASES; injury to the PHRENIC NERVE; and other disorders. [MeSH]
MedDRA Code 10038708
MeSH ID D012133
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Respiratory paralysis | Respiratory Paralysis | Paralysis, Respiratory | Paralysis, Respiratory Muscle | Muscle Paralyses, Respiratory | Muscle Paralysis, Respiratory | Respiratory Muscle Paralysis | Diaphragmatic Paralysis | Paralysis, Diaphragmatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00115Amiodarone0.000135%
BADD_D00308Bupivacaine--
BADD_D00309Bupivacaine hydrochloride--
BADD_D00747Edrophonium--
BADD_D00748Edrophonium chloride--
BADD_D01165Insulin lispro--
BADD_D01287Lidocaine--
BADD_D01339Magnesium cation--
BADD_D01387Mepivacaine--
BADD_D01553Neostigmine0.000179%
BADD_D01564Nicotine--
BADD_D01808Potassium cation--
BADD_D01881Pyridostigmine--
BADD_D01968Ropivacaine hydrochloride--
The 1th Page    1    Total 1 Pages